Desi Peneva, MS
Associate Director, Policy & Economics
Ms. Peneva has extensive expertise in evidence synthesis, evidence generation, and scientific communication in various therapeutic areas including oncology, diabetes, HIV/AIDS, multiple sclerosis, rheumatoid arthritis, cardiovascular and respiratory diseases, and maternal and infant disorders. Ms. Peneva has contributed to over 60 health economics and policy research studies at Precision Health Economics, including claims data analyses, predictive models, and health economic evaluations demonstrating the value of innovation to society. As an Associate Director, Ms. Peneva manages a team of research scientists while providing guidance on research best practices and quality assurance to the team’s portfolio of research projects. Ms. Peneva’s graduate studies and research focused on development and international economics, with an emphasis on poverty and indicators of human development.
MS, Economics, Illinois State University
BS, Finance, Minnesota State University
- Goldman DP, et al. Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood). 2013.
- MacEwan JP, et al. The relationship between adherence and total spending among Medicare beneficiaries with type 2 diabetes. Am J Manag Care. 2017.
- Snider JT, et al. The impact of state AIDS drug assistance policies on clinical and economic outcomes of people with HIV. Med Care Res Rev. 2016.
- Sood N, et al. HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care. Health Aff (Millwood). 2014.
- Stevens W, et al. Short-term costs of preeclampsia to the United States health care system. Am J Obstet Gynecol. 2017.